Synthesis of some NH-derivatives of ciprofloxacin as antibacterial and antifungal agents
Five NH-derivatives of ciprofloxacin (2-6) have been prepared by acetylation/benzoylation on ciprofloxacin (1) in order to carry out screening for antibacterial activities on some Gram-positive and Gram-negative bacteria. The antifungal activity of these compounds has also been made against Candida albicans. All of the derivatives have shown enhanced activities against Gram-negatives bacteria than parent antibiotic, ciprofloxacin among which compounds 2 and 6 are the most potent agents. Regarding the antifungal activity all of the compounds have shown highest activity than ciprofloxacin. All the compounds have been characterized with spectral analysis.
Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis: III. Comparison of one-or-two-dose ciprofloxacin with standard 5 day therapy: A randomized, blinded trial. Ann Intern Med. 1992; 117: 727-34.
Crumplin GC, Smith JT. Nalidixic acid bacterial chromosome replication. Nature 1976; 260: 643-45
de Souza NJ, Gupte SV, Deshpande PK, Desai VN, Bhawsar SB, Yeole RD, Shukla MC, Strahilevitz J, Hooper DC, Bozdogan B, Appelbaum PC, Jacobs MR, Shetty N, Patel MV, Jha R, Khorakiwala HF. A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus. J Med Chem. 2005; 48: 5232-42.
Devnath HP, Islam MR. Synthesis of some pyrazolone derivatives from ciprofloxacin and study of their cytotoxicity. Bangladesh J Pharmacol. 2010; 5: 30-33.
Goots TD, Brighty KE. Fluoroquinolone antibacterials: SAR, mechanism of action, resistance and clinical aspects. Med Res Rev. 1996; 16: 433-86.
Hooper DC, Wolfson JS. Fluoroquinolone antibacterial agents. N Engl J Med. 1991; 324: 384-94.
Jubie S, Sikdar P, Kalirajan R, Gowramma B, Gomaathy S, Sankar S, Elanga K. Synthesis and antimicrobial activity of some novel ciprofloxacin analogues. J Pharma Res. 2010; 3: 511-13.
Ludlam HA, Barton I, White L, McMullin C, King A, Phillips I. Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). J Antimicrob Chemother. 1990; 25: 843-51.
Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C, Gerding. DN. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med. 1989; 86: 801-08.
Siddiqui R, Sultana N, Khan KM, Akbar N, Ali M, Arayne S. Effects of skeletal modifications of ciprofloxacin on antibacterial, antifungal and cytotoxic activities. J Chinese Clin Med. 2007; 21: 188-95.
Wang JC. DNA topoisomerases. Annu Rev Biochem. 1985; 54: 665-97.
Yamashita Y, Ashizawa T, Morimoto M, Hosomi J, Nakano H. Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity. Cancer Res. 1992; 52: 2818-22.
Copyright (c) 2011 Md. Golam Rabbani, Md. Rabiul Islam, Mesbahuddin Ahmad, Abugafar Md. Lokman Hossion
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).